Takashi Eto
Hakata-ekimae, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Pharmacokinetics, Safety, and Immunogenicity of DMB-3115, a Ustekinumab Biosimilar for Immune-Mediated Diseases, in Healthy Japanese Male Participants: A Randomized, Double-Blind, Single-Dose Study.
Journal: Advances in therapy
Published: May 28, 2026
Validation of Assessment of Medication Swallowability by Surface Electromyography Measurement: Evaluating the Effect of Capsule Size on Medication Adherence.
Journal: Cureus
Published: November 07, 2025
Safety and Immunogenicity of 1 or 2 Additional Doses of the Adjuvanted Recombinant Zoster Vaccine Administered 5-6 Years After Primary Vaccination in Adults ≥50 Years.
Journal: Open forum infectious diseases
Published: September 26, 2025
Pharmacokinetics and safety of gadopiclenol in Japanese healthy volunteers.
Journal: Japanese journal of radiology
Published: February 21, 2025
Final analysis of the ZOE-LTFU trial to 11 years post-vaccination: efficacy of the adjuvanted recombinant zoster vaccine against herpes zoster and related complications.
Journal: EClinicalMedicine
Published: January 08, 2025
Pharmacological characteristics of once-weekly insulin icodec in Japanese individuals with type 1 diabetes.
Journal: Journal of diabetes investigation
Published: October 07, 2024
Pharmacokinetics, safety, and efficacy of daridorexant in Japanese subjects: Results from phase 1 and 2 studies.
Journal: Journal of sleep research
Published: April 17, 2024
Pharmacokinetics and Safety of Intravenous Candidate Biosimilar CT-P47 and Reference Tocilizumab: A Randomized, Double-Blind, Phase 1 Study.
Journal: Journal of clinical pharmacology
Published: March 27, 2024
A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Single Vaccination of Ad26.RSV.preF-Based Regimen in Japanese Adults Aged 60 Years and Older.
Journal: Influenza and other respiratory viruses
Published: June 06, 2023
Safety, tolerability, and pharmacokinetics of half-life extended SARS-CoV-2-neutralizing monoclonal antibodies AZD7442 (tixagevimab/cilgavimab) in healthy Japanese adults.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: April 18, 2023
Pharmacokinetics and Bioequivalence of Mirogabalin Orally Disintegrating Tablets and Conventional Tablets in Healthy Japanese Participants.
Journal: Clinical pharmacology in drug development
Published: January 23, 2023
Last Updated: 09/26/2026